How these Field Guides stay current
Every claim on these pages is monitored and re-checked automatically. This page describes how it's done.
Last re-checked August 3, 2026
How these pages maintain themselves
A Field Guide looks like any other well-researched page. The difference is underneath: every checkable claim (a drug's phase, an approval, an efficacy figure) is registered with the source and the query that verified it. That turns each claim into something a machine can re-check. Most uses of AI focus on content generation. Instead, this one helps keep content accurate and up-to-date.
Claims differ in how fast they go stale and whether the change is visible in our database or only on the web, so they're watched on four lanes:
Nightly database replay
Each of these claims ships with the exact database query that verified it. Every night we re-run the query and compare the result to what the page says. A changed number flags the claim.
Nightly entity watch
We track the drugs and trials each claim depends on. When a new trial phase, regulatory action, or press release touches one of them, the claim is flagged for a fresh look, usually within a day of the event.
Scheduled web re-check
Facts that live only on the web (a foreign approval, a company's guidance) can't be queried, so each carries a re-check date. When it comes due, a focused agent re-verifies just that claim against its sources.
Editorial sweep
Every claim is also re-walked in a periodic full editorial pass. This backstop catches what the nightly lanes can't, like a competitor's approval or a story that needs reframing.
A claim can sit on more than one lane, so these counts overlap. The first three run automatically every night; the editorial sweep is periodic.
A lane flags a claim as possibly stale.
An agent re-verifies it and writes a proposed edit.
A person checks the edit against the sources and adjusts if needed.
Approved edits are written back to the card and registry.
The page and this dashboard both update.
Detection and drafting are automated. Publishing is not: every change to a card is reviewed and approved by a person before it goes live.
Every Field Guide, at a glance
See the tracker behind the guides
The same daily pipeline that keeps these claims verified powers GLP-1 Observer: clinical trials, news, and regulatory milestones across the obesity-drug landscape, with date-change alerts and weekly roll-ups.